🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma Follicular › Indiana

Qorannoo klinikaalii Lymphoma Follicular Indiana keessatti

Qorannoo 7 Lymphoma Follicular f Indiana keessatti hirmaatuu jiru.

Magaalota Indiana keessatti

Takkalaa qorannoo (Ingiliffa)

5HTP Regulation Of Asthma In Children

  • Indiana University, Indianapolis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT04160910

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • Research Site, Fort Wayne
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06549595

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  • Investigative Clinical Research of Indiana, Noblesville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06091254

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Indiana University, Indianapolis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Indiana Blood and Marrow Transplantation, Indianapolis
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  • Indiana University and Comprehensive Cancer Center, Indianapolis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06149286

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • American Oncology Partners, Fort Wayne
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Mud-2025 · NCT05602363

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.